Guides
/
Gut Health

Staphylococcus aureus in Your Gut: What Carriage May Signal

REVIEWED BY
William Maish, MD MBA MPH
Clinical Product Lead
Published
November 4, 2025
Last updated
June 4, 2026
Key takeaway:

This stool-based test detects whether you are carrying Staphylococcus aureus, including methicillin-resistant strains (MRSA), in your gut microbiome. Many people carry S. aureus without symptoms, so the test reports presence and, where relevant, antibiotic-resistance markers. Higher gut carriage is associated with reduced microbial balance, so knowing your status may help inform a conversation with your clinician.

Read more →
Table of contents

Detecting Staphylococcus aureus carriage in your gut

A staphylococcus aureus test, in a gut-microbiome context, detects whether S. aureus is present in your stool and, where relevant, whether it carries genes associated with methicillin resistance (MRSA). Labs use DNA-based methods such as metagenomic sequencing or targeted PCR -- which can flag the mecA/mecC resistance genes -- to identify the organism within your broader microbial community and compare its abundance with a reference population. Results reflect your current ecosystem state -- whether you are carrying the organism in your gut without symptoms or at higher relative levels -- rather than a fixed trait.

Why this matters: S. aureus is best known as a resident of the nose and skin, but DNA-based stool testing also detects it as part of the gut community in some people, where it is read as carriage -- the organism living within your microbiome. When the microbiome is diverse and stable, low-level carriage of organisms like this tends to stay quiet; when diversity drops or the community is disrupted, the balance of less-common members can shift. Detecting it, and any resistance markers, gives one data point in the larger picture of your gut ecosystem.

What gut carriage helps put in context

Connecting biology to daily life, a carriage readout can help clarify whether your gut community includes S. aureus, at what level, and whether resistance markers like MRSA are present, which is useful information to share with your care team. It is most meaningful in context -- alongside the rest of your microbial profile -- rather than on its own. It can also put recent events into perspective, such as a course of antibiotics, a hospital stay, or an illness that reshapes which organisms dominate.

Zooming out, the gut microbiome influences barrier function, immune calibration, and metabolism, and its resilience comes largely from diversity. Tracking carriage of various organisms over time, alongside diversity metrics, can show whether microbiome-friendly inputs -- fiber variety, fermented foods, sleep, and stress management -- are moving your ecosystem toward a more balanced state. The goal isn't to sterilize the gut; it's to understand your carriage status and respond appropriately with your clinician.

Reading a carriage report

Your report typically states whether S. aureus was detected in your stool, its relative abundance compared with a reference population, and whether resistance markers (such as those linked to MRSA) are present. Detection indicates gut carriage, not a diagnosis.

A “reassuring” pattern usually means the organism is absent or present only at low levels within an otherwise diverse, balanced microbiome. That profile tends to align with steadier digestion and calmer local immune signaling, though individual biology and context matter. Many healthy adults intermittently carry S. aureus somewhere in the body without symptoms.

Higher gut carriage, or detection alongside low overall diversity, is associated with a less-balanced ecosystem. MRSA-associated markers may indicate genes associated with antibiotic resistance and are worth sharing with your clinician. These findings are part of a bigger picture -- symptoms, exam, and other labs help determine what, if anything, they mean for you.

Putting Staphylococcus aureus carriage in perspective

Over time, repeating the test can show whether carriage clears or persists and how it tracks with changes in your microbiome. Interpreted alongside your history and overall diversity, this data supports pattern recognition and informed, measured next steps with your care team rather than a stand-alone conclusion.

FAQs

The Staphylococcus aureus test analyzes the genetic material (DNA/RNA) of bacteria, fungi, and other microorganisms in stool to identify species diversity, relative abundance, and functional potential, revealing which microbes are present and the genes they carry that relate to metabolism, virulence, or resistance.

Results describe the microbial balance and community function in the sample—how abundant different organisms are and what they might be capable of—but do not by themselves diagnose illness or prove that S. aureus (or any organism) is causing disease; clinical correlation and targeted diagnostic tests are required for infection confirmation.

The staphylococcus aureus test is a simple at‑home stool collection: your kit will include a small swab or a sealed vial—use the swab to pick up a small amount of stool or place a small scoop into the vial exactly as the kit instructions describe, then securely close the container for return or drop‑off.

Maintain strict cleanliness (wash hands before and after, avoid touching the swab tip or the inside of the vial), clearly label the sample with the required information (name, date, and any kit ID), and follow the kit’s packing, storage, and shipping instructions precisely to ensure accurate sequencing results.

Staphylococcus aureus test results show whether S. aureus is detected in your stool, its relative abundance, and whether resistance markers such as those linked to MRSA are present - read as gut carriage rather than active infection. Detection is most meaningful as one signal of overall microbial diversity and balance, and any MRSA-associated markers are worth sharing with your clinician.

These microbiome patterns can correlate with, but don't diagnose, specific health conditions, and presence does not prove causation; discuss findings with a healthcare professional to understand their relevance and next steps.

The accuracy and reliability of Staphylococcus aureus tests depend on the method and sample quality: traditional culture and rapid PCR assays are generally reliable for detecting the organism when present, while next‑generation sequencing (NGS) provides much higher-resolution microbial data and can detect low-abundance strains and resistance genes. However, interpretation is probabilistic — tests estimate the likelihood of presence, abundance, or resistance rather than providing absolute certainty, and a positive result may indicate colonization rather than active infection.

Results reflect a snapshot in time and can change with sampling site, laboratory methods, sample handling, and patient factors; they may vary after recent antibiotic use, or with physiological changes such as diet and stress that alter microbial communities, so clinical context and repeat or complementary testing are often needed to guide decisions.

Many people test their Staphylococcus aureus once per year to establish a baseline, or every 3–6 months if they are actively adjusting diet, taking probiotics, or using other interventions and want to monitor changes.

More important than any single reading is the trend over time — using a consistent sampling method and the same test/lab when possible makes comparisons meaningful so you can track whether colonization or counts are increasing, decreasing, or stable rather than over-interpreting a one-off result.

Yes — microbial populations, including those of staphylococcus aureus, can change quickly: short-term shifts in diet, medication, hygiene or other lifestyle factors can alter community composition within days. However, more stable patterns of colonization and relative abundance generally emerge over weeks to months as transient changes settle and new equilibria form.

For meaningful comparisons or repeat testing, aim for consistent lifestyle and dietary habits for several weeks before retesting so you’re more likely to detect true, sustained changes rather than short-term fluctuations.

References

  1. Raineri, E. J. M., Altulea, D., & van Dijl, J. M. (2022). Staphylococcal trafficking and infection—from 'nose to gut' and back. FEMS Microbiology Reviews, 46(1), fuab041. https://doi.org/10.1093/femsre/fuab041
  2. Stegger, M., Andersen, P. S., Kearns, A., Pichon, B., Holmes, M. A., Edwards, G., Laurent, F., Teale, C., Skov, R., & Larsen, A. R. (2012). Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecA(LGA251). Clinical Microbiology and Infection, 18(4), 395–400. https://doi.org/10.1111/j.1469-0691.2011.03715.x
  3. Fassarella, M., Blaak, E. E., Penders, J., Nauta, A., Smidt, H., & Zoetendal, E. G. (2021). Gut microbiome stability and resilience: Elucidating the response to perturbations in order to modulate gut health. Gut, 70(3), 595–605. https://doi.org/10.1136/gutjnl-2020-321747
  4. de Vos, W. M., Tilg, H., Van Hul, M., & Cani, P. D. (2022). Gut microbiome and health: Mechanistic insights. Gut, 71(5), 1020–1032. https://doi.org/10.1136/gutjnl-2021-326789
  5. Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., Holland, T. L., & Fowler, V. G. (2019). Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research. Nature Reviews Microbiology, 17(4), 203–218. https://doi.org/10.1038/s41579-018-0147-4

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey